NASDAQ · Key Statistics

TELA Bio, Inc. (TELA) P/E Ratio, ROE & Key Statistics

$0.76 NASDAQ: TELA Market Cap $34.44M

Data as of Nov 17, 2026 close · Source: Financial Modeling Prep (methodology)

Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for TELA Bio, Inc. (TELA), each with what it measures. Figures are trailing twelve months or the most recent reported period.

Valuation

MetricValue
P/E ratioShare price divided by earnings per share.-1.11
P/B ratioShare price divided by book value per share.-1.93
P/S ratioMarket value divided by annual revenue.0.47
PEG ratioP/E divided by the earnings growth rate.-0.06
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.-2.15
EV / RevenueEnterprise value against annual revenue.0.90
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.-90.09%
Free cash flow yieldFree cash flow as a percentage of market value.-92.80%
Price / free cash flowMarket value divided by free cash flow.-1.08

Profitability

MetricValue
Gross marginRevenue left after the direct cost of goods sold.67.19%
Operating marginRevenue left after operating costs.-43.17%
Net marginRevenue left after every cost, including tax and interest.-53.57%
Return on equityProfit as a percentage of shareholders’ equity.425.91%
Return on assetsProfit as a percentage of total assets.-84.61%
Return on capital employedOperating profit against the capital the business uses.144.45%

Financial health

MetricValue
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.0.61
Quick ratioThe same, excluding inventory.0.45
Cash ratioCash alone against current liabilities.2.83
Debt to equityTotal borrowings against shareholders’ equity.-2.29
Debt to assetsTotal borrowings against total assets.0.69
Interest coverageHow many times operating profit covers the interest bill.-8.98

Per share and size

MetricValue
Earnings per shareProfit attributable to each share.−$0.83
Book value per shareShareholders’ equity divided by shares outstanding.−$0.43
Market capitalisationShare price times shares outstanding.$34.44M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.$70.06M
EmployeesReported headcount.209

Dividend

MetricValue
Dividend yieldAnnual dividend as a percentage of the share price.0.00%

TELA Bio, Inc. (TELA) statistics — frequently asked questions

What is TELA Bio, Inc.'s P/E ratio?

TELA Bio, Inc. (TELA) trades on a price-to-earnings ratio of -1.11. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.

What is TELA Bio, Inc.'s return on equity?

TELA Bio, Inc. (TELA) reports a return on equity of 425.91%, meaning it generated that much profit for every dollar of shareholders' equity.

How much debt does TELA Bio, Inc. carry?

TELA Bio, Inc. (TELA) has a debt-to-equity ratio of -2.29, which compares total borrowings with shareholders' equity.

What is TELA Bio, Inc.'s profit margin?

TELA Bio, Inc. (TELA) keeps -53.57% of revenue as net profit after every cost, including tax and interest.

P/E and ROE of other Medical - Devices stocks

ABT P/E 38.41ISRG P/E 54.04MDT P/E 23.33SYK P/E 31.57BSX P/E 18.42EW P/E 59.08RMD P/E 20.92DXCM P/E 30.09PHG P/E 26.93ZBH P/E 26.95All Medical - Devices stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.